BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 27381492)

  • 1. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
    Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A
    Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.
    Guedj N; Maggiori L; Poté N; Norkowski E; Cros J; Bedossa P; Panis Y
    Hum Pathol; 2016 Jun; 52():164-72. PubMed ID: 27210028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.
    de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM
    Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis.
    Persiani R; Biondi A; Pennestrì F; Fico V; De Simone V; Tirelli F; Santullo F; D'Ugo D
    Dis Colon Rectum; 2018 Jul; 61(7):809-816. PubMed ID: 29771810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study].
    Hoch J; Ferko A; Bláha M; Ryška A; Čapov I; Dušek L; Feit J; Grega M; Hermanová M; Hovorková E; Chmelová R; Kala Z; Klos D; Kodet R; Langer D; Hadži-Nikolov D; Örhalmi J; Páral J; Tichý M; Tučková I; Vjaclovský M; Vlček P
    Rozhl Chir; 2016; 95(7):262-71. PubMed ID: 27523174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
    Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
    Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Yield After Neoadjuvant Chemoradiotherapy in Rectal Cancer Specimens: A Randomized Trial Comparing Two Fixatives.
    Dias AR; Pereira MA; de Mello ES; Nahas SC; Cecconello I; Ribeiro U
    Dis Colon Rectum; 2018 Aug; 61(8):888-896. PubMed ID: 29944580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
    Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
    Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
    Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
    Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
    Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer.
    Debove C; Maggiori L; Chau A; Kanso F; Ferron M; Panis Y
    Int J Colorectal Dis; 2015 Feb; 30(2):197-203. PubMed ID: 25466419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.
    Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J
    Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
    Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
    Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients.
    Burke JP; Martin-Perez B; Khan A; Nassif G; de Beche-Adams T; Larach SW; Albert MR; Atallah S
    Colorectal Dis; 2016 Jun; 18(6):570-7. PubMed ID: 26749148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
    Debove C; Guedj N; Tribillon E; Maggiori L; Zappa M; Panis Y
    Int J Colorectal Dis; 2016 Apr; 31(4):853-60. PubMed ID: 26951185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.
    Miller ED; Robb BW; Cummings OW; Johnstone PA
    Dis Colon Rectum; 2012 Sep; 55(9):1002-7. PubMed ID: 22874609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.